Expanding treatment options for lower limb ischaemia with Diamond-F self-expanding drug-eluting stent
Global Vascular Co., Ltd. is a developer of a drug-eluting stent delivery system for lower limb artery disease, which achieves the world's first cutting-edge endovascular treatment using nanotechnology.
Our Vision
Towards a future where the simple act of walking is a given, we strive.
News
How it works
Key Technology
The stent surface is equipped with BIOZONE Coating® technology, a nanotechnology that suppresses thrombus adhesion. By further suppressing the release of harmful nickel ions in the body, this technology allows for endothelialization, the process by which cells integrate with the stent, without inhibiting it, enabling a stent treatment that is gentle on the body.
Our Partners
Company Profile
Company Name
Global Vascular Co., Ltd.
Representative
Keneta BITO, Shunto MAEGAWA
Founded
12/12/2022
Capital
251,999,995JPY
Location
Ichigaya Science and Technology Innovation Center Building 2F, 3-8 Ichigayatamachi, Shinjuku-ku, Tokyo, JAPAN 162-0843
Business description
Design and development of medical equipment, research, consulting, etc.
Investor
Diamond Medino Capital Inc.